FHTX
Foghorn Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.90
-0.02 ▼ -0.41%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$4.90
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -1.22 | Insider Own | 49.68% | Shs Outstand | 0.06B | Perf Week | -15.22% |
| Market Cap | 0.29B | Forward P/E | - | EPS next Y | -3.64% | Insider Trans | - | Shs Float | 0.03B | Perf Month | -9.59% |
| Enterprise Value | 0.17B | PEG | - | EPS next Q | -0.28 | Inst Own | 39.7% | Short Float | 3.99% | Perf Quarter | 10.11% |
| Income | -0.07B | P/S | 9.31 | EPS this Y | 15.57% | Inst Trans | 1.06% | Short Ratio | 6.76 | Perf Half Y | -7.2% |
| Sales | 0.03B | P/B | - | EPS next 5Y | 11.79% | ROA | -17.42% | Short Interest | 1.18M | Perf YTD | -9.26% |
| Book/sh | -1.92 | P/C | 1.8 | EPS past 3/5Y | 23.34% 8.8% | ROE | - | 52W High | -29.5% ($6.95) | Perf Year | 9.38% |
| Cash/sh | 2.73 | P/FCF | - | Sales past 3/5Y | 17.14% 135.14% | ROIC | - | 52W Low | 66.4% ($2.94) | Perf 3Y | -5.95% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 27.97% | Gross Margin | 88.91% | Volatility(W/M) | 10.37% 7.35% | Perf 5Y | -60.96% |
| Dividend TTM | - | EV/Sales | 5.46 | Sales Y/Y TTM | 36.75% | Oper. Margin | -265.64% | ATR (14) | 0.42 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.73 | EPS Q/Q | -9.01% | Profit Margin | -240.33% | RSI (14) | 35.78 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.73 | Sales Q/Q | 223.77% | SMA20 | -12.34% ($5.59) | Beta | 3.13 | Target Price | $11.12 |
| Payout | - | Debt/Eq | - | Earnings | 3000000 | SMA50 | -13.14% ($5.64) | Rel Volume | 1.32 | Prev Close | $4.92 |
| Employees | 106 | LT Debt/Eq | - | EPS/Sales Surpr. | -32.58% -14.3% | SMA200 | -3.02% ($5.05) | Avg Volume(3M) | 0.17M | Price | $4.9 |
| IPO | 2020/10/23 | Option/Short | Yes/Yes | Trades | 2241 | Volume | 229,608 | Change | -0.41% |
뉴스 로딩 중...